Industry Effort to Combat COVID-19
The Biopharmaceutical Industry is Leading the Way in Developing New Vaccines and Treatments for COVID-19
New Report Shows Nearly 260 Vaccines in Development, Including Dozens for COVID-19
To the Millions Affected by COVID-19
Working Together to Fight COVID-19
pixiv稳定梯子
The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
latest from the
Blog
-
Payers subject 80% of new RA and MS patients to utilization management restrictions
-
The latest: What they are saying: intellectual property protections critical as we work to defeat COVID-19
-
PhRMA submits comments to CMS on Medicaid proposed rule
-
New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19
90%
OF ALL CLINICAL TRIALS
are led by the biopharmaceutical industry
$1.1
trillion
人生游戏修改器_第一章:钓鱼软件?_起点中文网_小说下载:2021-8-4 · 人生游戏修改器最新章节阅读,人生游戏修改器是一部轻小说小说,由天黑要睡觉创作,起点提供首发更新。最后一句话是 ...
pixiv稳定梯子
industry sponsored clinical trials
are currently underway
4.7
million jobs
are supported by America's biopharmaceutical companies
45%
of all Medicare acute hospitals participate in 340B.
30,000
340B sites enrolled as of May 2015.
88%
decline in hiv/aids death rates
Since the 1990s
80%
of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.
1,500
new safe and effective medications
have been delivered to patients, thanks to PDUFA.
1,100+
cancer treatments
are in clinical testing
550
new medicines
Approved by the Food and Drug Administration since 2000.
$2.6
billion
The average cost to develop one new medicine.
8
months
Priority FDA review time thanks to PDUFA
74%
of medicines in development
have the potential to be first in class medicines
160+
medicines in development
for diabetes and related conditions
80+
autoimmune diseases
have been identified to-date
$3.5
million
Average yearly amount PhRMA Foundation awards to young scientists
7,000
new medicines
Currently in development around the world.